Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
REPL Quote, Financials, Valuation and Earnings
Last price:
$12.51
Seasonality move
:
-4.36%
Day range:
$12.03 - $13.19
52-week range:
$6.44 - $17.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.34x
Volume:
4.1M
Avg. volume:
1.5M
1-year change:
14.2%
Market cap:
$973.6M
Revenue:
--
EPS (TTM):
-$3.07
Earnings Data
Next earnings date for REPL
Aug 08
2025
Most recent earnings per share
-$0.82
Missed by $0.13
(May 22/2025)
Consensus Estimate
-$0.69
(May 22/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
REPL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $6.6M | -- | -- | -$0.80 | -- |
| 08/08/2025 | Q2 | $1.3M | -- | -- | -$0.85 | -- |
| 05/22/2025 | Q1 | -- | -- | -$0.82 | -$0.69 | -$0.13 |
| 02/12/2025 | Q4 | -- | -- | -$0.79 | -$0.72 | -$0.07 |
| 11/12/2024 | Q3 | -- | -- | -$0.68 | -$0.74 | $0.06 |
| 08/08/2024 | Q2 | -- | -- | -$0.78 | -$0.84 | $0.05 |
| 05/16/2024 | Q1 | -- | -- | -$0.82 | -$0.80 | -$0.02 |
| 02/08/2024 | Q4 | -- | -- | -$0.77 | -$0.94 | $0.17 |
| 11/07/2023 | Q3 | -- | -- | -$0.90 | -$0.89 | -$0.01 |
| 08/03/2023 | Q2 | -- | -- | -$0.75 | -$0.84 | $0.09 |
| 05/18/2023 | Q1 | -- | -- | -$0.74 | -$0.66 | -$0.08 |
| 02/09/2023 | Q4 | -- | -- | -$0.69 | -$0.74 | $0.05 |
| 11/03/2022 | Q3 | -- | -- | -$0.79 | -$0.76 | -$0.03 |
| 08/04/2022 | Q2 | -- | -- | -$0.78 | -$0.56 | -$0.22 |
| 05/19/2022 | Q1 | -- | -- | -$0.60 | -$0.60 | -$0.00 |
| 02/03/2022 | Q4 | -- | -- | -$0.57 | -$0.57 | $0.00 |
| 11/04/2021 | Q3 | -- | -- | -$0.56 | -$0.52 | -$0.04 |
| 08/06/2021 | Q2 | -- | -- | -$0.53 | -$0.42 | -$0.11 |
| 05/20/2021 | Q1 | -- | -- | -$0.41 | -$0.38 | -$0.03 |
| 02/04/2021 | Q4 | -- | -- | -$0.44 | -$0.41 | -$0.03 |
| 11/05/2020 | Q3 | -- | -- | -$0.46 | -$0.44 | -$0.02 |
| 08/07/2020 | Q2 | -- | -- | -$0.44 | -$0.43 | -$0.01 |
| 06/03/2020 | Q1 | -- | -- | -$0.41 | -$0.43 | $0.02 |
| 02/13/2020 | Q4 | -- | -- | -$0.46 | -$0.36 | -$0.10 |
| 11/11/2019 | Q3 | -- | -- | -$0.35 | -$0.34 | -$0.01 |
| 08/14/2019 | Q2 | -- | -- | -$0.30 | -$0.31 | $0.01 |
| 06/28/2019 | Q1 | -- | -- | -$0.15 | -$0.42 | $0.27 |
| 02/14/2019 | Q4 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 11/14/2018 | Q3 | -- | -- | -$0.26 | -$0.20 | -$0.07 |
| 08/30/2018 | Q2 | -- | -- | -$0.42 | -$0.21 | -$0.21 |
Replimune Group Earnings Questions
-
How Much did Replimune Group Generate in Revenue Last Quarter?
Replimune Group reported -- worth of top line sales in its most recent quarter.
-
Did Replimune Group Beat Earnings Last Quarter?
Replimune Group announced earnings per share of -$0.82 which represents a miss of analyst forecast a -$0.69 per share.
-
Is Replimune Group Profitable?
Replimune Group reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Replimune Group EPS Next Year?
Replimune Group's earnings are forecast to decrease from -$3.07 per share to -$2.81 per share next year representing a decrease of -6.77%.
-
When is Replimune Group's Earnings Date?
Replimune Group's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
